share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

SEC announcement ·  May 4 04:29
Summary by Futu AI
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 9,555 shares of common stock on May 2, 2024. The transaction was executed in the open market at a price of $8.7378 per share, resulting in a total sale value of approximately $83,489.68. Following the sale, Burnett's direct holdings in the company amount to 259,745 shares of common stock.
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 9,555 shares of common stock on May 2, 2024. The transaction was executed in the open market at a price of $8.7378 per share, resulting in a total sale value of approximately $83,489.68. Following the sale, Burnett's direct holdings in the company amount to 259,745 shares of common stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.